Cargando…
Online monitoring of patient self-reported adverse events in early phase clinical trials: Views from patients, clinicians, and trial staff
BACKGROUND/AIMS: New classes of cancer drugs bring a range of unknown and undesirable adverse events. Adverse event monitoring is essential in phase I trials to assess toxicity and safety. In phase II, the focus is also on efficacy but robust data on adverse events continue to inform the safety and...
Autores principales: | Kennedy, Fiona, Shearsmith, Leanne, Ayres, Michael, Lindner, Oana C, Marston, Lewis, Pass, Alison, Danson, Sarah, Velikova, Galina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010887/ https://www.ncbi.nlm.nih.gov/pubmed/33231103 http://dx.doi.org/10.1177/1740774520972125 |
Ejemplares similares
-
Delphi survey to inform patient-reported symptom monitoring after ovarian cancer treatment
por: Shearsmith, Leanne, et al.
Publicado: (2020) -
‘We do need to keep some human touch’—Patient and clinician experiences of ovarian cancer follow‐up and the potential for an electronic patient‐reported outcome pathway: A qualitative interview study
por: Kennedy, Fiona, et al.
Publicado: (2022) -
‘It made me feel part of the team, having my homework to do’ — women and specialist nurse experiences of remote follow-up after ovarian cancer treatment: a qualitative interview study
por: Kennedy, Fiona, et al.
Publicado: (2022) -
Electronic patient-reported monitoring of symptoms during follow-up of ovarian cancer patients: a feasibility study
por: Kennedy, Fiona, et al.
Publicado: (2022) -
The Sexunzipped Trial: Young People’s Views of Participating in an Online Randomized Controlled Trial
por: Nicholas, Angela, et al.
Publicado: (2013)